Nursing 2027

Although pregnancy is viewed as a “healthy medical experience” for a woman, the old adage is when all goes well, it is great and when it is bad, it can be unbelievably bad with significant morbidity/mortality outcomes. Monitoring of BP in the antenatal and intrapartum period is part of the routine therapeutic treatment. This is followed by a brief monitoring period during the postpartum period. One assumes that once the fetus has been delivered, there is no longer a sustained need for BP monitoring.
This study focuses on the importance of BP monitoring throughout pregnancy and extending beyond the postpartum delivery period in order to help improve health outcomes. A review of EBP resources will serve as the framework for BP therapeutic monitoring highlighting potential complications that can occur which can impact health outcomes. Selected clinical examples will be provided that highlight health concerns during and after the pregnancy experience. Monitoring of BP for the pregnant woman extends beyond the antenatal, intrapartum and post-partum period. Pregnancy, even as considered to be a healthy medical event in a women’s life, places significant metabolic stressors which may continue to impact the women’s health status up to 1 year following a delivery

Dr. Wane has a PhD in Nursing Science and MSN from University of South Florida. She is a Board-Certified Nurse Practitioner. After 32 years in academia, she is a Nurse Consultant. She has published supplements in textbooks. She is an editorial board member and peer reviewer for several journal publications.